Navigation Links
WuXi PharmaTech Files 2011 Annual Report on Form 20-F
Date:4/20/2012

SHANGHAI, April 20, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2011 with the Securities and Exchange Commission.  The annual report can be accessed on WuXi PharmaTech's website at http://www.wuxiapptec.com under the Investor Relations/SEC Filings section.  WuXi PharmaTech will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements free of charge to its shareholders and ADS holders upon request.  Requests should be directed to Ronald Aldridge, Director of Investor Relations, by email at ir@wuxiapptec.com.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States.  As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec.  For more information, please visit: http://www.wuxiapptec.com .

For more information, please contact:

WuXi PharmaTech (Cayman) Inc.
Ronald Aldridge (for investors)
Director of Investor Relations
Tel: +1-201-585-2048
Email: ir@wuxiapptec.com

Harry He (for the media)
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com

<
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
8. WuXi PharmaTech Announces First-Quarter 2010 Results
9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight ... The conventional methods developed to prevent and eradicate the ... treatment. These methods are confined to low specificity, safety ... researchers to look for a better solution. It has ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... -- ChemImage will present a workshop focused on hyperspectral ... Science Society,s 22 nd International Symposium on ... .  Forensic Scientists will be in attendance ... can bring to examination procedures. ... Development at ChemImage, will host a workshop during ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... FRANCISCO, Calif., June 01, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... from ongoing clinical,studies of SNS-595 and SNS-032 at ... being held June 7-10, 2007 in Vienna,Austria. , ... Phase 1 clinical trial of SNS-595 in acute ...
... Zurich, June 1, 2007-Cytos Biotechnology AG is ... presentations of its novel,immunotherapeutic CYT003-QbG10 to treat ... were obtained,and will be presented in different ... Academy of Allergology and Clinical Immunology,(EAACI), taking ...
Cached Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
(Date:8/29/2014)... 2014 A recent article discusses ... a Tokyo clothing store for men with gynecomastia, or male ... or diminishing their problem. Board-certified plastic surgeon Dr. Chasan is ... While many people only associate male breasts with men who ... among men of all ages, often starting in adolescence. Men ...
(Date:8/29/2014)... regarded audiologist , Dr. Mary Ann Larkin has written 4 ... are titled:, , Revealing the Truth About Tinnitus ... The Top 5 Things You Should Know Before Buying a ... , Dr. Mary Anne Larkin choose to write about ... misinformation about each them. The reports are available for immediate ...
(Date:8/29/2014)... August 29, 2014 Healthpointe is pleased ... has joined their practice. Dr. Chuang garners extensive experience ... in minimally-invasive arthroscopic and reconstructive treatments of the knees, ... patients with general and sports-related orthopedic needs. ... medical field. As an Orange County native, he graduated ...
(Date:8/29/2014)... Fort Worth, TX (PRWEB) August 29, 2014 ... the practice website to provide hearing health care tips ... The newly established blog section will offer weekly articles ... broad range of topics including the latest advances in ... to frequently asked questions. The audiologists plan to write ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe is Honored to Induct Orthopedic Surgeon into Their Team 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Take Steps to Control Bunions 2
... BLOOD DETECTIVES -- a documentary from Peabody-Award-winning filmmaker Joseph Lovett in ... 19 at 7:00 PM ET/PT on Discovery Health , ... ... Lovett, in conjunction with the American Society of Hematology ...
... Information Systems, Inc., (Berkshire) a leading provider of e-commerce fulfillment solutions ... Pharmaco LLC. Pharmaco LLC is the supplier of Invisible Veins, ... ... Lenox, MA (PRWEB) November 12, 2008 -- Berkshire Information Systems, Inc. ...
... developed at Bristol University that could revolutionise the way ... at North Bristol NHS Trust (NBT). , Professor Alan ... Bristol have been working for a number of years ... and therefore has no radiation risk unlike conventional mammograms. ...
... Fundamental Fractional Patent Families, MOUNTAIN VIEW, ... Technologies, Inc. and Palomar Medical Technologies, Inc. ... Fractional Technology Open Patent,Program ("FTOPP") to offer ... property in the fractional space. The FTOPP ...
... 11 NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), a ... results for the fiscal fourth,quarter and fiscal year ended ... ended September 30, 2008, net sales were,$602 million compared ... fourth,quarter ended September 30, 2007, an increase of $105 ...
... the condition, doctors say , , TUESDAY, Nov. 11 (HealthDay ... exercise and medications to manage and improve the lives ... more than 5 million Americans. , One ... or hospitalization rates from any cause, as well as ...
Cached Medicine News:Health News:Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health 2Health News:Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health 3Health News:Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC 2Health News:Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC 3Health News:New technology could revolutionize breast cancer screening 2Health News:New technology could revolutionize breast cancer screening 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 4Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 2Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 3Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 4Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 5Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 6Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 7Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 8Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 9Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 10Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 11Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 12Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 13Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 14Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 15Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 16Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 17Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 18Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 19Health News:Gains Against Heart Failure Reported 2Health News:Gains Against Heart Failure Reported 3
... The wrap frame is constructed of ... while minimizing potential breakage. The molded ... a full saddle bridge to distribute weight ... peripheral vision with leaded glass side shields. ...
... Constructed of optical steel base ... overlay. Comes with custom fitted ... create a seal to the ... from oblique angle exposure. Includes ...
... protection Properly manufactured radiation protective eyewear ... Our high quality frames and materials offer ... weight. Our lenses are made of Schott ... industry standards. Most Pulse Glasses are offered ...
... frames are designed with the safety and comfort ... Schott RS-520 (also called SF-6) leaded glass, the ... meet standards, as set for optical clarity, visible ... our eyewear is protecting your eyes, it also ...
Medicine Products: